Overcoming HMA Failure in MDS: HMAs in HR-MDS, Induction Chemo (CPX-351), IDH Inhibitors, Olaparib in IDH-Mutated Disease, IO in Advanced Disease (Ipi+/-Nivo+/-Aza, Pembro)
By
Yale Cancer Center
FEATURING
Thomas Prebet
By
Yale Cancer Center
FEATURING
Thomas Prebet
Login to view comments.
Click here to Login
